p27kip1: a new multiple endocrine neoplasia gene?
Ilaria Marinoni1, Natalia S Pellegata
1Institute of Pathology, Helmholtz Zentrum München, Neuherberg, Germany.
Abstract:
Multiple endocrine neoplasias (MEN) are autosomal dominant disorders characterized by the occurrence of tumors in at least two endocrine glands. Two types of MEN syndromes have long been known: MEN type 1 (MEN1) and MEN type 2 (MEN2), associated with a different spectrum of affected organs. MEN1 and MEN2 are caused by germline mutations in the MEN1 tumor suppressor gene and the RET proto-oncogene, respectively. Lately, a new type of MEN was identified (named MEN4) which is due to mutations in the CDKN1B gene, encoding for p27kip1 (p27), a cyclin-dependent kinase (Cdk) inhibitor that regulates the transition of cells from G1 to S phase. p27 is a non-canonical tumor suppressor since it is usually not somatically mutated in human cancers but it is often downregulated by post-translational mechanisms. The discovery of MEN4 has defined a new role for CDKN1B as a tumor susceptibility gene for multiple endocrine tumors. To date, six germline CDKN1B mutations have been found in patients with a MEN1-like phenotype but negative for MEN1 mutations. Due to the limited number of patients so far identified, the phenotypic features of MEN4 are not clearly defined. Here, we review the clinical and molecular characteristics of the MEN4 syndrome and summarize the main functions of p27 to better comprehend how their alteration can predispose to neuroendocrine tumors.
Insights
Multiple endocrine neoplasia type 4 (MEN4) is a newly identified disorder caused by mutations in the CDKN1B gene. This syndrome highlights a new role for CDKN1B in susceptibility to multiple endocrine tumors.
Area of Science:
- Endocrinology
- Oncology
- Genetics
Background:
- Multiple endocrine neoplasias (MEN) are inherited disorders involving tumors in multiple endocrine glands.
- MEN type 1 (MEN1) and MEN type 2 (MEN2) are well-characterized, caused by mutations in MEN1 and RET genes, respectively.
- A novel MEN syndrome, MEN4, has been identified, linked to the CDKN1B gene.
Purpose of the Study:
- To review the clinical and molecular characteristics of MEN4.
- To summarize the functions of p27kip1 (p27) and its role in MEN4.
- To understand how CDKN1B alterations predispose to neuroendocrine tumors.
Main Methods:
- Literature review of clinical and molecular data for MEN4 patients.
- Analysis of the functions of p27kip1 (p27) as a cyclin-dependent kinase inhibitor.
- Review of germline mutations in the CDKN1B gene associated with MEN4.
Main Results:
- MEN4 is caused by germline mutations in the CDKN1B gene, encoding the tumor suppressor p27.
- Six germline CDKN1B mutations have been identified in patients with a MEN1-like phenotype.
- The precise phenotypic features of MEN4 are still being defined due to limited patient numbers.
Conclusions:
- The discovery of MEN4 establishes CDKN1B as a tumor susceptibility gene for multiple endocrine tumors.
- Understanding p27's functions is crucial for comprehending MEN4 pathogenesis.
- Further research is needed to fully characterize MEN4 phenotypes and their genetic basis.
Related Concept Videos
Abnormal Proliferation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

